Berlin, March 4 (AFP/APP): German group Curevac said Thursday it has signed a deal with Novartis for the Swiss pharmaceutical giant to help in its production of the Covid-19 vaccine it is developing. The Swiss giant will make up to 50 million doses of Curevac’s mRNA vaccine by the end of 2021 and up to 200 million doses … Continue reading Curevac signs a deal with Novartis for Swiss pharmaceutical help